Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088179
Status:
COMPLETED
Last Update Posted:
2018-02-22
First Post:
2004-07-21
Brief Title:
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass PRIMO-CABG II
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Organization Data
Organization:
Alexion Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
2003141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alexion Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Procter and Gamble | INDUSTRY |